
Evotec and Sanofi have entered negotiations for a major multi-component strategic alliance worth around €250 million over the next five …

Development of Evotec and Hyperion Therapeutic’s diabetes drug DiaPep277 has been terminated following ‘serious misconduct’ in one of its trials. …

